14 articles for KJ Shin
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification and characterization of potent, selective and metabolically stable IKKß inhibitor.

The Catholic University of Korea
Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent.

The Catholic University of Korea
Synthesis and structure-activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer's disease.

Korea Institute of Science and Technology
Discovery of potent and selective rhodanine type IKKß inhibitors by hit-to-lead strategy.

Korea University
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.

National Institute of Diabetes
Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.

Korea Institute of Science and Technology
Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitors.

Korea Institute of Science and Technology
IKKbeta inhibitors identification part II: ligand and structure-based virtual screening.

Institute of Science and Technology
Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.

Institute of Science and Technology
Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents.

Korea Institute of Science & Technology (Kist)
Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker.

The Catholic University of Korea
Small molecules that protect against β-amyloid-induced cytotoxicity by inhibiting aggregation of β-amyloid.

Korea Institute of Science and Technology
Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Abeta fibril formation.

Korea Institute of Science and Technology
Design, synthesis and biological evaluation of novel thiazolidinedione derivatives as irreversible allosteric IKK-β modulators.

Korea Institute of Science & Technology (Kist)